Article Contents ::
- 1 Details About Generic Salt :: Cefadrox
- 2 Main Medicine Class::
- 3 (SEFF-uh-DROX-ill) Duricef Class: Antibiotic/cephalosporin
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Cefadrox
Main Medicine Class::
(SEFF-uh-DROX-ill)
Duricef
Class: Antibiotic/cephalosporin
Drugs Class ::
Action Inhibits mucopeptide synthesis in bacterial cell wall.
Indications for Drugs ::
Indications Treatment of infections of urinary tract, skin and skin structures; treatment of pharyngitis and tonsillitis due to susceptible strains of specific microorganisms.
Drug Dose ::
Route/Dosage
ADULTS: PO 1–2 g/day in single dose or two divided doses. CHILDREN: PO 30 mg/kg/day in single dose or two divided doses.
Contraindication ::
Contraindications Hypersensitivity to cephalosporins.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Excreted in breast milk. Children: In infants, consider benefits relative to risks. Drug may accumulate in neonates. Hypersensitivity: Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients due to possible cross-reactivity. Pseudomembranous colitis: Should be considered in patients in whom diarrhea develops. Renal impairment: Use drug with caution in patients with renal impairment. Dosage adjustment based on renal function may be required. Superinfection: May result in bacterial or fungal overgrowth of nonsusceptible microorganisms.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
GI: Nausea; vomiting; diarrhea; anorexia; abdominal pain or cramps; flatulence; colitis, including pseudomembranous colitis. GU: Pyuria; renal dysfunction; dysuria; reversible interstitial nephritis; hematuria; toxic nephropathy. HEMA: Eosinophilia; neutropenia; lymphocytosis; leukocytosis; thrombocytopenia; decreased platelet function; anemia; aplastic anemia; hemorrhage. HEPA: Hepatic dysfunction, abnormal liver function test results. OTHER: Hypersensitivity, including Stevens-Johnson syndrome, erythema multiforme and toxic epidermal necrolysis; serum sickness–like reactions (eg, skin rash, polyarthritis, arthralgia, fever); candidal overgrowth.
Drug Mode of Action ::
Action Inhibits mucopeptide synthesis in bacterial cell wall.
Drug Interactions ::
Interactions
Probenecid: Inhibition of renal excretion of cefadroxil.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note renal impairment and allergy to cephalosporins or penicillins.
- Obtain specimens for culture and sensitivity before beginning therapy and periodically during treatment.
- Monitor renal function carefully during treatment.
- Monitor for signs of infection, especially fever, and for positive response to antibiotic therapy.
- Assess for signs and symptoms of anaphylaxis (shortness of breath, wheezing, laryngeal spasm). Have resuscitation equipment available.
- Assess for symptoms of superinfection, such as vaginitis or stomatitis.
- Assess for severe diarrhea with blood or pus, which may be symptom of pseudomembranous colitis. Symptoms may occur after antibiotic treatment.
|
Drug Storage/Management ::
Administration/Storage
- Administer with food or milk if GI upset occurs.
- Oral suspension must be refrigerated and will remain stable for up to 14 days. Do not freeze. Shake well before use.
Drug Notes ::
Patient/Family Education
- Instruct patient to complete full course of therapy.
- Instruct patient to check body temperature daily. If fever persists more than a few days or if high fever (> 102°F) or shaking chills are noted, physician should be notified immediately.
- Advise patient to maintain normal fluid intake while using this medication.
- Advise diabetic patient to use enzyme-based tests (eg, Clinistix, Testape) for monitoring urine glucose because drug may give false results with other tests.
- Instruct patient to report these symptoms to physician: nausea, vomiting, diarrhea, skin rash, hives, muscle or joint pain.
- Instruct patient to report signs of superinfection: black “furry” tongue, white patches in mouth, foul-smelling stools, vaginal itching or discharge.
- Warn patient that diarrhea that contains blood or pus may be a sign of serious disorders. Tell patient to seek medical care and not to treat at home. Instruct patient to seek emergency care immediately if wheezing or difficulty in breathing occurs.